Outpace Bio last raised $144.0M in its Early Stage VC (Series B) (Jul 2024).
- ·The complete investor list: 20 names
- ·Watch Outpace Bio: the Monday email on marks, rounds and moves
Outpace Bio funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Early Stage VC (Series B) | $144.0M | ▮ | ▮ |
Membership and data by Private Market View
Outpace Bio valuation
Outpace Bio's last known valuation is $220 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Outpace Bio raised?
Outpace Bio has raised $199 million in total; 1 of its rounds is on record. The largest on record was a $144 million Series B in Jul 2024.
Outpace Bio has filed 1 Form D with the SEC, most recently in Aug 2024 ($56 million sold to 25 investors).
Comparable companies
Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: Scipher Medicine ($496 million), TRIANA Biomedicines ($258 million) and Nature's Toolbox ($71 million).
How Outpace Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Outpace Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Outpace Bio
- What is Outpace Bio worth?
- Outpace Bio's last known valuation is $220.0M.
- How much has Outpace Bio raised?
- Outpace Bio has raised $199.0M in total funding across 1 recorded rounds.
- When did Outpace Bio last raise?
- Outpace Bio last raised in Jul 2024 (Early Stage VC (Series B)), raising $144.0M.